This event will feature two talks focusing on the cutting-edge use of digital PCR (dPCR) for research, exploring CAR-T cell monitoring in clinical research phases and high-throughput adeno-associated ...

HILDEN, Germany & GERMANTOWN, Md.--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced new additions to the growing number of applications for QIAcuity, its ...

Recent advancements in nanotechnology have significantly influenced the evolution of polymerase chain reaction (PCR) techniques. By integrating nanomaterials such as metal nanoparticles, graphene ...

DUBLIN--(BUSINESS WIRE)--The "Polymerase Chain Reaction (PCR) Technologies and Global Markets 2023-2028" report has been added to ResearchAndMarkets.com's offering. PCR is a powerful molecular biology ...

Digital PCR is a specialized tool for nucleic acid quantification, which has applications in many research areas including those in microbiology and virology research. Leveraging optical multiplexing, ...

Simplify and accelerate the creation of your lyophilized amplification assay to expedite the development of your point-of-care application. Promega has dedicated time to perfecting reagent ...

No significant financial relationships to disclose. This is an ASCO Meeting Abstract from the 2005 ASCO Annual Meeting. This abstract does not include a full text component.

PCR technology, owned and licensed through Hoffmann-La Roche Inc., a Swiss-based pharmaceutical company with United States headquarters in Nutley, N.J., is considered by many to be the most important ...

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, and NuProbe USA, a genomics and molecular diagnostics company, recently ...

Polymerase chain reaction (PCR) and rapid (antigen) tests for COVID-19 both involve taking a swab. Results for a PCR test take longer, as it needs to go to a laboratory. It is more costly but tends to ...

Little Rock, Arkansas-based Revolution has received a letter of no objection (LNO) from the U.S Food and Drug Administration (FDA) for the company’s proprietary recycling method for linear low-density ...